15.12.2010 • NewsSanofiIsraelinvestment

Hadasit Bio-Holdings is an Investment Interest for Sanofi-Aventis

French drugmaker Sanofi-Aventis is in talks to invest in Hadasit Bio-Holdings, the Israeli biotech holding company said on Tuesday.

Hadasit said the potential investment would be in its KHAR Medical unit, but that no deal had yet been reached. It noted that it was responding to a report in Israel's Calcalist newspaper.

Hadasit, the technology transfer company of Jerusalem's Hadassah University Hospital, said the deal could be thwarted by the disclosure of the talks in the newspaper.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.